Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?
暂无分享,去创建一个
[1] D. Brand,et al. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction. , 1995, Journal of the American College of Cardiology.
[2] L Pilote,et al. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.
[3] M. Radford,et al. Process and Outcome of Care for Acute Myocardial Infarction among Medicare Beneficiaries in Connecticut: A Quality Improvement Demonstration Project , 1995, Annals of Internal Medicine.
[4] S. Viskin,et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. , 1995, Journal of the American College of Cardiology.
[5] H. Kennedy,et al. Beta-blocker therapy in the cardiac arrhythmia suppression trial , 1994 .
[6] J. Alpert,et al. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. , 1992, The American journal of medicine.
[7] K. Teo,et al. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989) , 1991, The American journal of cardiology.
[8] J. Fleiss,et al. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group. , 1990, Journal of the American College of Cardiology.
[9] F. Klocke,et al. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.
[10] L. Rydén,et al. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. , 1989, European heart journal.
[11] I. Wiklund,et al. Physical inactivity as a risk factor for primary and secondary coronary events in Göteborg, Sweden. , 1988, European heart journal.
[12] R. Byington,et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. , 1986, Circulation.
[13] N. Rehnqvist,et al. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. , 1985, Journal of the American College of Cardiology.
[14] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[15] T. Gundersen. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. , 1983, British heart journal.
[16] P. Hoff,et al. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. , 1982, British medical journal.
[17] E. Gilpin,et al. Diabetic patients and beta-blockers after acute myocardial infarction. , 1990, European heart journal.